Biogenist Pharma Main Player in Infertility Treatment-PDF

Embed Size (px)

Citation preview

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    1/58

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    2/58

    .

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    3/58

    .

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    4/58

    .

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    5/58

    Company IntroductionBiogenist (Pvt) Ltd started its operation in the year 2004.

    It is a part of a group of companies engaged in diversified businesses.

    Our initial focus is on the specialty of Obs / Gynee particularly Infertility

    Management.

    Biogenist has also entered into the Branded Generic Segment with the aim ofproviding effective & economical medicines for the entire community

    .

    .

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    6/58

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    7/58

    Vision

    By 2016 Biogenist will be known to

    the Practicing Gynecologists as a

    company caring the entire basichealthcare needs of a common

    person.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    8/58

    All Infertility Centers of Pakistan Lahore Institute of Fertility & Endocrinology (LIFE) Lahore

    Australian Concept Infertility Medical Center - Karachi

    Baqai Institute of Reproductive Sciences (BIRDS) Karachi

    Sind Institute of Reproductive Medicine (SIRM) - Karachi

    Islamabad Clinic Serving Infertile Couples (Pvt) Ltd - Islamabad

    Infertility Services (Pvt) Ltd - Islamabad

    Gynecological Advisory Services - Islamabad

    Aga Khan University Hospital

    Armed Forces Institution of Pakistan

    Practicing Gynecologists

    .

    Our Working Spectrum

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    9/58.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    10/58

    Biogenist Pharma

    Chief Executive

    Officer

    . 1

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    11/58. 1

    THANK YOU

    Biogenist Pharma (Pvt) Ltd

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    12/58

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    13/58

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    14/58

    . 14

    Infertility is a very common condition affectingapproximately 13-14% of couples in the reproductive

    age group. Although this prevalence has remained stable over the

    last few years, the demand for infertility services hasincreased substantially.

    This increase is due primarily to the Baby Boomgeneration entering into the reproductive age group ata time of highly publicized technological advances.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    15/58

    . 15

    Definition of Infertility & ART

    Common causes of infertility

    Who is eligible for ART

    Methodology of ovulation induction Improving SPA

    Other techniques

    Counseling couple Failure rate

    Cost effectiveness

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    16/58

    . 16

    Infertility is defined classically as the inability to

    conceive after 1 year of unprotected intercourse.This definition is based on the cumulativeprobability of pregnancy:

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    17/58

    . 17

    Month Monthly Probability Cumulative Probability

    1 0.2 0.20

    2 0.2 0.36

    3 0.2 0.49

    4 0.2 0.595 0.2 0.67

    6 0.2 0.74

    7 0.2 0.79

    8 0.2 0.83

    9 0.2 0.8610 0.2 0.89

    11 0.2 0.91

    12 0.2 0.93

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    18/58

    . 18

    ART refers to all techniques involvingdirect retrieval of oocytes from theovary

    ART procedures include IVF, GIFT,ZIFT, and ICSI.

    The simplest ART procedure, IVF hasbeen around for over 20 years and is

    perhaps the most commonlyrecognized ART of all procedures.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    19/58

    . 19

    Causes of Infertility

    Cause Couples Women

    Male 35% N/A

    Ovulatory 15% 40%

    Tubal 35% 40%

    Unexplained 10% 10%

    Other 5% 10%

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    20/58

    . 20

    Female factors

    Cervical factor

    Ovulatory factor (PCOs)

    Uterine factor (endometriosis)

    Pelvic factor

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    21/58

    . 21

    Polycystic Ovarian Syndrome (PCOS)Also known as Stein-Leventhal syndrome

    Also known as hyperandrogenic chronic anovulation is a benign

    disorder that commonly results in infertility.PCOS is characterized by irregular ovulation and menses, obesity,insulin resistance, acne, and hirsutism.Most women with PCOS also have ovaries filled with multiplebenign cysts.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    22/58

    . 22

    How does PCOS contribute to Infertility?

    Impaired fertility is a prominent feature of PCOS.

    This is believed to result from elevated insulin levels that

    stimulate excess androgen production by the ovaries.

    The androgens cause premature follicular wasting whichcauses inconsistent or absent ovulation, which is

    associated with infertility.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    23/58

    . 23

    Symptoms

    Irregular or absent periods

    Lack of ovulation Weight gain Hirsutism (excessive hair growth) Insulin resistance Acne Male-pattern balding

    Multiple small ovarian cysts-these may be seen by an ultrasoundexamination

    Ancthosis nigrans (darkening of the skin at the nape of the neck andunder the arms and breasts).

    http://images.google.com.pk/imgres?imgurl=http://2.bp.blogspot.com/_B9CmlJEV37o/SXazrxkC7RI/AAAAAAAAAEc/CfB5wHruscg/s320/05.jpg&imgrefurl=http://yogaforobesity.blogspot.com/2009/01/pcod-disease-that-worries-woman.html&usg=__cOGyQmck6zIsf1y-q5GZx84YDEs=&h=275&w=312&sz=19&hl=en&start=1&um=1&itbs=1&tbnid=8_BKaDuoaHTrRM:&tbnh=103&tbnw=117&prev=/images?q=PCOD&um=1&hl=en&sa=G&tbs=isch:1
  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    24/58

    . 24

    Diagnosis

    :Blood Work/Hormonal Testing:

    Laboratory testing is important for diagnosis but it is

    crucial to look at multiple values collectively.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    25/58

    . 25

    Diagnosis:

    3. Ultrasound:

    Ultrasound of the pelvis is typically performed when the

    clinician suspects PCOS.

    If >10 cysts are found in either ovary that are less than10mm, this meets the ultrasound criteria for PCOS.Furthermore, polycystic ovaries are typically 1.5 to 3 timesthe normal size.

    Just the presence of polycystic ovaries, without symptomsand/or consistent blood work, does not confirm a diagnosisof PCOS.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    26/58

    . 26

    Treatment

    Weight Loss, Progestins, Oral Contraceptives,

    Anti-Androgens, GnRH agonists, Fertility drugs,

    Surgical therapy:

    a) Ovarian wedge resection b) Laparoscopic ovarian drilling

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    27/58

    . 27

    Endometriosis

    Endometriosis can be defined as a nonmalignantdisorder in which functioning endometrial tissue ispresent outside the uterus.

    The incidence of this disease ranges from 10-15% inwomen between the ages of 25 and 44 who areactively menstruating, but it also occurs in teenagers.

    It is estimated that 25-50% of infertile women havethis disease.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    28/58

    Endometriosis

    . 28

    The incidence is higher in first degree relatives of

    women with endometriosis, which suggests that

    heredity may play a role.

    In addition, there is also a higher prevalence of the

    disease in women who delay childbearing or who are

    of Asian descent.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    29/58

    . 29

    Causes and Symptoms

    The cause of endometriosis is unknown, however there areseveral theories.

    The first theory is known as retrograde menstruation, or themovement of sloughed endometrial tissue back through thefallopian tubes and into the abdominal cavity. This tissue canthen attach itself to various internal organs or tissues outside ofthe uterus.

    Immune system dysfunction. It is believed that certain womenmay develop endometriosis due to deficiencies in their immunesystem.

    Endometriosis

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    30/58

    . 30

    In women without endometriosis, the immunesystem destroys any ectopic implants that maydevelop. However, in women with endometriosis,there is an altered immune response and the body isunable to destroy the growth of the implants.

    Furthermore, some scientists believe thatendometriosis is an autoimmune disorder. Thismeans that the body makes antibodies toendometrial cells. These antibodies may destroy the

    healthy endometrium found in the uterus, but areineffective in destroying ectopic implants.

    Endometriosis

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    31/58

    . 31

    Symptoms

    Pelvic pain and cramping before and duringperiods

    Pain during intercourse

    Inability to conceive

    Fatigue

    Painful urination during periods

    Gastrointestinal symptoms such as diarrhea,constipation, and nausea

    Endometriosis

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    32/58

    . 32

    There are other medical conditions that have similarsymptoms and should be considered prior to making adiagnosis of endometriosis. Conditions that may causegeneralized pelvic pain include:

    Pelvic inflammatory disease (PID) Pelvic adhesions

    Neoplasms (cancers), both benign or malignant

    Ovarian torsion

    Sexual or physical abuse

    Other causes that are not gynecologic in nature

    Endometriosis

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    33/58

    . 33

    How does endometriosis contribute toinfertility?

    The cause of infertility is believed to result from the

    scarring and adhesions that form in the reproductivetract as a result of inflammation.

    Scar tissue and adhesions may reduce fertility by either

    obstructing or distorting the shape of the fallopian

    tubes, which in turn impedes the passage of sperm to

    the egg.

    Endometriosis

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    34/58

    . 34

    In the event that sperm do reach the egg, they

    may encounter a hostile environment

    unfavorable to fertilization.

    Finally, scarring from endometriosis may

    obstruct the fallopian tubes so that if an egg is

    fertilized, it may be unable to travel to the uterus

    for implantation.

    Endometriosis

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    35/58

    . 35

    Diagnosis

    One of two techniques may be used to confirm thediagnosis of endometriosis. Both procedures involvevisualization of the pelvic cavity in order to confirm

    the presence or absence of ectopic implants. laparoscopy

    laparotomy

    If there are any suspected ectopic implants, they arebiopsied in order to determine the presence of

    endometrial cells.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    36/58

    . 36

    Women with tubal diseases

    Unexplained infertility

    Endometriosis

    Immunologic causes for infertility

    Women with premature ovarian failure

    Individuals with male factor infertility (e.g.,abnormalities in sperm production, function

    or transport or prior vasectomy)

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    37/58

    . 37

    Basically, this term refers to the use of medications

    to stimulate your body to produce one or more

    eggs.

    Ovulation induction can be as simple as taking a

    daily pill or more complicated, like injecting

    fertility medications and seeing your specialist

    daily for necessary monitoring. The simplest form

    of ovulation induction involves taking clomiphene.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    38/58

    . 38

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    39/58

    . 39

    More potent medications, known as the gonadotropins,are available for more intensive ovulation induction.

    Gonadotropins are injectable medications that are madeup of a combination of follicle stimulating hormone (FSH)and luteinizing hormone (LH) or just FSH alone.

    These hormones can be very helpful in getting a woman to

    produce and release her eggs.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    40/58

    . 40

    The success of ovulation induction in achieving a

    pregnancy is highly variable. It depends on the

    diagnosis, age, the medication being used, and

    numerous other factors.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    41/58

    . 41

    Sperm penetration assay (SPA) is a multi-step laboratory

    test that offers a biological assessment of human spermfertilizing ability.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    42/58

    . 42

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    43/58

    . 43

    ZIFT

    GIFT

    TEST

    POST

    ICSI

    TESE

    MESA

    PGD

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    44/58

    . 44

    ZIFT

    Zygote Intrafallopian Transfer. ZIFT may berecommended if the husband has severe male fertility factor or if there has been difficulty confirming

    fertilization with past procedures. ZIFT has theadvantages of allowing fertilization to be confirmedand it has demonstrated higher success rates thanIVF when used for the appropriate indications.

    One disadvantage with ZIFT is that the transfer of the

    zygote must be performed through a laparoscope.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    45/58

    . 45

    GIFT

    Gamete intrafallopian transfer was developing in 1984 as avariation of in vitro fertilization (IVF).

    Gift is recommended when

    unexplained infertility

    infertility due to immunological factors

    endometriosis

    selected cases of male infertility

    Tubal infertility

    A requirement for the procedure is that the female partnerhaving at least one open (patent) fallopian tube.

    http://images.google.com.pk/imgres?imgurl=http://www.netterimages.com/images/vpv/000/000/004/4082-0550x0475.jpg&imgrefurl=http://www.netterimages.com/image/4082.htm&usg=__ldH7Cz99ssa1MptPlIhI7YA9F8k=&h=550&w=475&sz=105&hl=en&start=176&um=1&itbs=1&tbnid=r2cVh2qXe7OqxM:&tbnh=133&tbnw=115&prev=/images?q=ZIFT&start=160&um=1&hl=en&sa=N&ndsp=20&tbs=isch:1http://images.google.com.pk/imgres?imgurl=http://www.netterimages.com/images/vpv/000/000/004/4082-0550x0475.jpg&imgrefurl=http://www.netterimages.com/image/4082.htm&usg=__ldH7Cz99ssa1MptPlIhI7YA9F8k=&h=550&w=475&sz=105&hl=en&start=176&um=1&itbs=1&tbnid=r2cVh2qXe7OqxM:&tbnh=133&tbnw=115&prev=/images?q=ZIFT&start=160&um=1&hl=en&sa=N&ndsp=20&tbs=isch:1
  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    46/58

    . 46

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    47/58

    . 47

    ICSI

    Intracytoplasmic sperm injection, or ICSI, was

    developed to treat couples who previously had a verypoor probability of achieving fertilization due to the

    male partner's extremely low numbers of viable

    sperm.

    This treatment, when combined with in vitrofertilization, allows these couples a more favorable

    probability of achieving conception.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    48/58

    . 48

    ICSI

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    49/58

    . 49

    TESE

    Testicular Sperm Extraction

    MESA Microsurgical Epididymal Sperm Aspiration

    What is Preimplantation Genetic Diagnosis?

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    50/58

    . 50

    PGD

    Preimplantation Genetic Diagnosis

    The Preimplantation Genetic Diagnosis (PGD) is a new method ofPrenatal Diagnosis. The aim of this study is to increase the chances of

    having a healthy baby and therefore, avoiding the chances of

    transmitting a genetic or hereditary disease. In order to perform the

    diagnosis we use high technology with each embryo

    http://www.geneticsandsociety.org/img/original/pgd2.jpg
  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    51/58

    What is Preimplantation Genetic Diagnosis?

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    52/58

    . 52

    PGD

    Preimplantation Genetic Diagnosis

    Preimplantation Genetic Diagnosis is recommended

    for those couples who are carriers or suffer from

    genetic or chromosomal diseases that aretransmissible to their offspring. It is also

    recommended for women of an advanced age, for

    women who have had repeated miscarriages, for

    patients undergoing fertility treatments who have failed several times to conceive through In Vitro

    Fertilization and finally for those couples who produce

    embryos with morphological alterations

    http://www.geneticsandsociety.org/img/original/pgd2.jpg
  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    53/58

    . 53

    The use of skills that enable a client to recognize andidentify his (sic) own problems, and the ability to helpclient find his own solution or resolution.

    The Human Fertilization and Embryology Authority

    (HFEA) state in their code of practice that three sortsof counseling must be available at licensed treatmentcenter. These are:

    Support counseling

    Implications counseling Therapeutic counseling

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    54/58

    . 54

    One of the first questions that most people ask is "what isthe chance for success?" The best estimate is that thebirth of a live baby occurs in approximately 15-25% of

    women in whom embryos are transferred into the uterus. The 1998 nationwide live birth rate as reported in the IVF-

    ET Registry, was 24.9%.

    The corresponding rate for 1989 was 14%.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    55/58

    . 55

    Success varies with many factors, including the numberof embryos that are transferred.

    If one embryo is transferred, there is approximately a

    7% chance of successful implantation; with twoembryos, the success rate increases to 18%.

    The rate peaks with the transfer of three to fourembryos. Presently, the collection of oocytes,fertilization, and early embryo growth are accomplished

    with a high degree of efficiency.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    56/58

    . 56

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    57/58

    . 57

    Twins occur in about 25% of ART pregnancies versus 1-2%of spontaneous pregnancies. The risk of more than atwin pregnancy is less than 5%.

    To put these figures into perspective, studies have shownthat the rate of pregnancy in couples with proven fertilityin the past is approximately 20% per cycle. Therefore,although a figure of 15-25% may sound low, it is equal toor greater than the chance that a fertile couple will

    conceive in any given cycle.

  • 8/14/2019 Biogenist Pharma Main Player in Infertility Treatment-PDF

    58/58

    We are all angels with only one wing.

    We can only fly while embracing each other.

    - Luciano D. Crecenzo

    Thank you!